Abstract
The non-Hodgkin’s lymphomas (NHL) represent multiple diseases with diverse morphologic and clinical expressions. Morphologic classification schemes such as that proposed by Rappaport have been shown to be useful in predicting the clinical course [1]. However, in some instances distinctive morphologic entities may be very closely related clinically and/or biologically, whereas other diseases that share morphologic similarities may be clinically and biologically quite distinct (Table I). The application of modern immunologic techniques and concepts has enabled us to develop a conceptual framework which we may use to decipher the morphologic diversity of these neoplasms [2]. This review will focus on the non-Hodgkin’s lymphomas presenting primarily in adult life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rappaport H (1966). Tumors of the hematopoietic system. Atlas of tumor pathology. Section 3, fascicle 8. Washington, D.C.: Armed Forces Institute of Pathology.
Mann RB, Jaffe ES and Berard CW (1979). Malignant lymphomas: A conceptual understanding of morphologic diversity. Amer J Pathol 94: 103–192.
Rosenberg SA (1979). Current concepts in cancer: Non-Hodgkin’s Lymphoma–Selection of treatment on the basis of histologic type. N Engl J Med 301: 924–928.
Rosenberg SA, Berard CW, Brown BW et al. (1982). National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 49: 2112–2135.
Jaffe ES (1983). Follicular lymphomas: Possibility that they are benign tumors of the lymphoid system. J Nat Cancer Inst 70: 401–403.
Braylan RC, Jaffe ES, Burbach JV et al. (1976). Similarities of surface characteristics of neoplastic well differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res 36: 1619–1625.
Pangalis GA, Nathwani BN and Rappaport H (1977). Malignant lymphoma, well differentiated lymphocytic. Its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenstrom. Cancer 39: 999–1000.
Cossman J and Jaffe ES (1981). Distribution of complement receptor subtypes in non-Hodgkin’s lymphomas of B cell origin. Blood 58: 20–26.
Fu SM, Chiorazzi N, Kunkel HG et al. (1978). Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med 148: 1570–1578.
Cossman J, Neckers LM, Braziel RM et al. (1984). In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia. J Clin Invest 73:587–592.
Martin PJ, Hansen JA, Nowinski RC et al. (1980). A new human T cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics II: 429–439.
Royston I, Majda JA, Baird SM et al. (1980). Human T cell antigens defined by monoclonal antigens: The 65,000 dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol 125: 725–731.
Caligaris-Cappio F, Gobbi M, Bofil M and Janossy G (1982). Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 155: 623–628.
Cossman J, Neckers LM, Hsu SM et al. (1984). Low grade lymphomas: Expression of developmentally regulated B-cell antigens. Amer J Pathol 114: 117–124.
Ferroni M, Viale G, Risso A and Pernis B (1976). A study of the immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol 6: 562–565.
Halper J, Fu SM, Wang CY et al. (1978). Patterns of expression of human ` Ia-like’ antigens during the terminal stages of B-cell development. J Immunol 120: 1480–1484.
Stashenko P, Nadler LM, Hardy R and Schlossman SF (1981). Expression of cell surface markers after human B lymphocyte activation. Proc Nat Acad Sci USA 78: 3848–3852.
Abramson C, Kersey J and Le Bien T (1981). A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol 126: 83–88.
Jaffe ES, Braylan RC, Nanba K et al. (1977). Functional markers: A new perspective on malignant lymphomas. Cancer Treat Rep 61: 953–962.
Nanba K, Jaffe ES, Braylan RC et al. (1977). Alkaline phosphatase-positive malignant lymphomas. A subtype of B-cell lymphomas. Amer J Clin Pathol 68: 535–542.
Swerdlow SH, Haveshaw JA, Murray LJ et al. (1983). Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. Amer J Pathol 113: 181–197.
Jaffe ES, Shevach EM, Frank MM et al. (1974). Nodular lymphoma. Evidence for origin from follicular B-lymphocytes. N Engl J Med 290: 813–819.
Harris NL and Bhan AK (1983). Distribution of T-cell subsets in follicular and diffuse lymphomas of B-cell type. Amer J Pathol 113: 172–180.
Braziel RM, Neckers LM, Jaffe ES and Cossman J (1983). Follicular (nodular) B-cell lymphomas: Immunoregulation of immunoglobulin secretion. Blood 62 (Suppl. 1): 187a.
DeVita VT, Canellos OP, Chabner BA et al. (1975). Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1: 248–250.
Jaffe ES (1980). Non-Hodgkin’s lymphomas as neoplasms of the immune system, pp 222–226. In: Berard CW, moderator. A multidisciplinary approach to non-Hodgkin’s lymphomas. Ann Intern Med 94: 218–235.
Jaffe ES, Strauchen JA and Berard CW (1982). Predictability of immunologic phenotype of morphologic criteria in diffuse aggressive non-Hodgkins’s lymphomas. Amer J Clin Pathol 77: 46–49.
Cossman J, Jaffe ES and Fisher RI. Immunologic phenotypes of diffuse aggressive non-Hodgkin’s lymphomas: Correlation with clinical features. Cancer (in press)..
Waldron JA, Leech JE, Glick AD et al. (1977). Malignant lymphoma of peripheral T-lymphocyte origin. Cancer 40: 1604–1617.
Pinkus GS, Said JW and Hargreaves H (1979). Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobulated nuclei, with a report of four cases. Amer J Clin Pathol 72: 540–550.
Jaffe ES, Cossman J and Fisher RI (1981). Immunologic, pathologic and clinical analysis of peripheral T-cell lymphomas. Blood 58 (Suppl. I): 551.
Doggett RS, Wood GS, Horning S et al. (1984). The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Amer J Pathol 115: 245–252.
Jaffe ES, Longo DL, Cossman J et al. (1984). Diffuse B-cell lymphomas with T-cell predominance in patients with follicular lymphomas or “ pseudo T-cell lymphomas ”. Lab Invest 50: 27–28a.
Arnold A, Cossman J, Bakhshi A et al. (1983). Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasma. N Engl J Med 309: 1593–1599.
Uchiyama T, Yodoi J, Sagawa K et al. (1977). Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50: 481–492.
Catovsky O, Greaves MF, Rose M et al. (1982). Adult T-cell lymphoma-leukemia in blacks from the West Indies. Lancet 1: 639–643.
Blayney DW, Jaffe ES, Blattner Wa et al. (1983). The human T-cell leukemia/lymphoma virus (HTLV) associated with American adult T-cell leukemia/lymphoma ( ATL ). Blood 62: 401–405.
Hanaoka M, Sasaki M, Matsumoto H et al. (1979). Adult T-cell leukemia: Histological classification and characteristics. Acta Pathol Jap 19 (5): 727–738.
Jaffe ES, Blattner WA, Blayney DW et al. (1984). The pathologic spectrum of HTLV-associated leukemia/lymphoma in the United States. Amer J Surg Pathol 8: 263–275.
Uchiyama T, Sagawak, Takatsuki K and Uchino H (1978). Effect of adult T-cell leukemia cells pokeweed mitogen-induced B-cell differentiation. Clin Immunol Immunopathol 10: 24–34.
Waldmann TA (1984). Function and phenotype of virus-associated neoplastic cells, pp. 553554. In: Broder S, moderator. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med 100: 543–557.
Grossman B, Schecter GP, Horton JE et al. (1981). Hypercalcemia associated with T-cell lymphoma-leukemia. Amer J Clin Pathol 75: 149–155.
Kassel SH, Echevarria RA and Guzzo FF (1969). Midline malignant reticulosis (so-called lethal midline granuloma). Cancer 23: 920–935.
Liebow AA, Carrington CB and Friedman RJ (1972). Lymphomatoid granulomatosis. Hum Pathol 3: 457–558.
De Remee RA, Weiland LH and McDonald TJ (1978). Polymorphic reticulosis, lymphomatoid granulomatosis: Two diseases or one? Mayo Clin Proc 53: 634–640.
Saldana MJ, Patchefsky AS, Israel H et al. (1977). Pulmonary angitis and granulomatosis. The relationship between histological features, organ involvement and response to treatment. Hum Pathol 8: 391–409.
Katzenstein A, Carrington CB and Liebow AA (1979). Lymphomatoid granulomatosis: A clinicopathologic study of 152 cases. Cancer 43: 360–373.
Fauci AS, Haynes BF, Costa J et al. (1982). Lymphomatoid granulomatosis, prospective clinical and therapeutic experience over ten years. N Engl J Med 306: 68–74.
Jaffe ES, Costa JC, Fauci A et al. (1983). Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Amer J Med 75: 741–748.
Colby TV and Carrington CB (1982). Pulmonary lymphomas simulating lymphomatoid granulomatosis. Amer J Surg Pathol 6: 19–32.
Jaffe ES. The pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. (in press).
Simrell CR, Crabtree GR, Cossman J et al. (1982). Stimulation of phagocytosis by a T-cell lymphoma derived lymphokine. In: Vitetta E (Ed.). B and T-Cell Tumors, 24:247–252. UCLA Symposia in Molecular and Cellular Biology. New York: Academic Press.
Risdall RJ, McKenna RW, Nesbit ME et al. (1979). Virus associated hemophagocytic syndrome, a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993–1002.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Jaffe, E.S., Cossman, O.J., Neckers, L.M., Braziel, R.M., Simrell, C.R. (1985). Immunologic phenotypes of non-Hodgkin’s lymphomas: Correlation with morphology and function. In: Cavalli, F., Bonadonna, G., Rozencweig, M. (eds) Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances. Developments in Oncology, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2607-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2607-6_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9632-4
Online ISBN: 978-1-4613-2607-6
eBook Packages: Springer Book Archive